These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16533165)

  • 1. The role of unbound drug in pharmacokinetics/pharmacodynamics and in therapy.
    Calvo R; Lukas JC; Rodriguez M; Leal N; Suarez E
    Curr Pharm Des; 2006; 12(8):977-87. PubMed ID: 16533165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein binding in antiretroviral therapies.
    Boffito M; Back DJ; Blaschke TF; Rowland M; Bertz RJ; Gerber JG; Miller V
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):825-35. PubMed ID: 14585213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of unbound fraction of pazopanib in vitro and in cancer patients reveals albumin as the main binding site.
    Imbs DC; Paludetto MN; Négrier S; Powell H; Lafont T; White-Koning M; Chatelut E; Thomas F
    Invest New Drugs; 2016 Feb; 34(1):41-8. PubMed ID: 26572909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and Pharmacodynamic Considerations for Drugs Binding to Alpha-1-Acid Glycoprotein.
    Smith SA; Waters NJ
    Pharm Res; 2018 Dec; 36(2):30. PubMed ID: 30593605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of plasma proteins, albumin and alpha 1-acid glycoprotein, to pharmacokinetics of a multi-targeted receptor tyrosine kinase inhibitor, sunitinib, in analbuminemic rats.
    Toyama Y; Ueyama J; Nomura H; Tsukiyama I; Saito H; Hisada T; Matsuura K; Hasegawa T
    Anticancer Res; 2014 May; 34(5):2283-9. PubMed ID: 24778032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of alpha-1-acid glycoprotein binding on pharmacokinetics and pharmacodynamics.
    Huang Z; Ung T
    Curr Drug Metab; 2013 Feb; 14(2):226-38. PubMed ID: 23092311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-1-acid glycoprotein directly affects the pharmacokinetics and the analgesic effect of methadone in the rat beyond protein binding.
    Rodriguez M; Ortega I; Soengas I; Leal N; Suarez E; Calvo R; Lukas JC
    J Pharm Sci; 2004 Nov; 93(11):2836-50. PubMed ID: 15452846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Plasma Protein Binding on the Pharmacokinetics of Erdafitinib: Results of an Integrated Cross-Study Analysis.
    Li LY; Guo Y; Gonzalez M; Ouellet D
    J Clin Pharmacol; 2020 Mar; 60(3):391-399. PubMed ID: 31602692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of plasma protein binding for pharmacokinetics and pharmacodynamics of the γ-secretase inhibitor RO4929097.
    Wu J; Lorusso PM; Matherly LH; Li J
    Clin Cancer Res; 2012 Apr; 18(7):2066-79. PubMed ID: 22351688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered pharmacokinetics of a novel anticancer drug, UCN-01, caused by specific high affinity binding to alpha1-acid glycoprotein in humans.
    Fuse E; Tanii H; Takai K; Asanome K; Kurata N; Kobayashi H; Kuwabara T; Kobayashi S; Sugiyama Y
    Cancer Res; 1999 Mar; 59(5):1054-60. PubMed ID: 10070963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on binding of drug to serum protein].
    Otagiri M
    Yakugaku Zasshi; 2009 Apr; 129(4):413-25. PubMed ID: 19336995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro protein-binding characteristics of delavirdine and its N-dealkylated metabolite.
    Chaput AJ; D'Ambrosio R; Morse GD
    Antiviral Res; 1996 Oct; 32(2):81-9. PubMed ID: 8891167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between blacks and whites in plasma protein binding of drugs.
    Johnson JA; Livingston TN
    Eur J Clin Pharmacol; 1997; 51(6):485-8. PubMed ID: 9112064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phencyclidine blood protein binding: influence of protein, pH and species.
    Owens SM; Mayersohn M; Woodworth JR
    J Pharmacol Exp Ther; 1983 Sep; 226(3):656-60. PubMed ID: 6887006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha 1-acid glycoprotein-binding as a factor in age-related changes in the pharmacokinetics of trimethoprim in piglets.
    Tagawa Y; Kokue E; Shimoda M; Son DS
    Vet Q; 1994 Mar; 16(1):13-7. PubMed ID: 8009812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of smoking on serum protein composition and the protein binding of drugs.
    Benedek IH; Blouin RA; McNamara PJ
    J Pharm Pharmacol; 1984 Mar; 36(3):214-6. PubMed ID: 6144765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the unbound concentration of atazanavir of interest in therapeutic drug monitoring?
    Metsu D; Seraissol P; Delobel P; Cinq-Frais C; Cuzin L; Izopet J; Chatelut E; Gandia P
    Fundam Clin Pharmacol; 2017 Apr; 31(2):245-253. PubMed ID: 27664801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered disposition and effect of lerisetron in rats with elevated alpha 1-acid glycoprotein levels.
    Jauregizar N; Calvo R; Suarez E; Quintana A; Raczka E; Lukas JC
    Pharm Res; 2001 Jun; 18(6):838-45. PubMed ID: 11474789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics in HAART and antibiotic therapy.
    Boffito M
    New Microbiol; 2007 Jul; 30(3):346-9. PubMed ID: 17802923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.